Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Benoit J. Van den Eynde
Based on 14 articles published since 2009
(Why 14 articles?)
||||
Expertise Level
The expertise of Benoit J. Van den Eynde ranks in the
  • Top 2.2%
  • ... of 106,334 published authors worldwide on Melanoma
  • ... from 2009 through 2019
  • ... based on contributions to 14 articles on the topic.
Graphical view (beta)
Aliases Van den Eynde, Benoit J   ·   Van den Eynde, Benoît   ·   Van den Eynde, B J   ·   Van den Eynde, Benoît J   ·   Van den Eynde, B
Work Locations
Details
Most likely:    Ludwig Institute for Cancer Research - Brussels      
2018
  • Ludwig Institute for Cancer Research, Brussels B-1200, Belgium. · de Duve Institute, University of Louvain, Brussels B-1200, Belgium. · Walloon Excellence in Life Sciences and Biotechnology, Brussels B-1200, Belgium. · Ludwig Institute for Cancer Research, Brussels B-1200, Belgium; · Department of Immunobiology, Yale University, New Haven, CT 06519; and · Department of Cell Biology, Yale University, New Haven, CT 06519. · Pubmed 30135181
2017
  • Ludwig Institute for Cancer Research, Brussels, B-1200, Belgium. · de Duve Institute, Université Catholique de Louvain, Brussels, B-1200, Belgium. · Walloon Excellence in Life Sciences and Biotechnology, Brussels, B-1200, Belgium. · Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université, Inserm, CNRS, Marseille, France. · Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, SE-17177, Sweden. · Ludwig Institute for Cancer Research, Brussels, B-1200, Belgium. · de Duve Institute, Université Catholique de Louvain, Brussels, B-1200, Belgium. · Walloon Excellence in Life Sciences and Biotechnology, Brussels, B-1200, Belgium. · Pubmed 29123081
2016
  • Institut für Biochemie, Charité-Universitätsmedizin Berlin, Charitéplatz 1, D-10117 Berlin, Germany. · Ludwig Institute for Cancer Research, WELBIO (Walloon Excellence in Life Sciences and Biotechnology) and the de Duve Institute, Université catholique de Louvain, Place de l'Université 1, B-1200 Brussels, Belgium. · Department of Dermatology, Universitätsklinikum Erlangen, Ulmenweg 18, D-91052 Erlangen, Germany. · Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Essen D - 45122 Essen, Germany &German Cancer Consortium (DKTK), Hufelandstraße 55, D-69120 Heidelberg, Germany. · Max-Delbrück-Center for Molecular Medicine, Robert-Rössle-Str. 10, D-13092 Berlin, Germany. · Institute of Biology, Humboldt University Berlin, Charitéplatz 1, D-10115 Berlin, Germany. · Pubmed 27049119
2015
  • Ludwig Institute for Cancer Research, Brussels and Université Catholique de Louvain, Brussels, Belgium. · de Duve Institute, Université Catholique de Louvain, Brussels, Belgium. · Pubmed 25853464
2014
  • Ludwig Institute for Cancer Research, B-1200 Brussels, Belgium; · Pubmed 24453253
2012
  • Ludwig Institute for Cancer Research, Brussels Branch, B-1200 Brussels, Belgium. · Pubmed 22925930
2011
  • Ludwig Institute for Cancer Research, Brussels Branch, Université Catholique de Louvain, B-1200 Brussels, Belgium. · Pubmed 21670269
  • de Duve Institute, Université Catholique de Louvain and Ludwig Institute for Cancer Research, Brussels Branch, Brussels, Belgium. · Pubmed 21216894
  • Ludwig Institute for Cancer Research, Brussels Branch, Belgium. · Pubmed 21207413
Probable:    Miscellaneous institutions in Brussels      
2018
  • Ludwig Institute for Cancer Research, Brussels B-1200, Belgium. · de Duve Institute, University of Louvain, Brussels B-1200, Belgium. · Walloon Excellence in Life Sciences and Biotechnology, Brussels B-1200, Belgium. · Ludwig Institute for Cancer Research, Brussels B-1200, Belgium; · Department of Immunobiology, Yale University, New Haven, CT 06519; and · Department of Cell Biology, Yale University, New Haven, CT 06519. · Pubmed 30135181
2017
  • Ludwig Institute for Cancer Research, Brussels, B-1200, Belgium. · de Duve Institute, Université Catholique de Louvain, Brussels, B-1200, Belgium. · Walloon Excellence in Life Sciences and Biotechnology, Brussels, B-1200, Belgium. · Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université, Inserm, CNRS, Marseille, France. · Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, SE-17177, Sweden. · Ludwig Institute for Cancer Research, Brussels, B-1200, Belgium. · de Duve Institute, Université Catholique de Louvain, Brussels, B-1200, Belgium. · Walloon Excellence in Life Sciences and Biotechnology, Brussels, B-1200, Belgium. · Pubmed 29123081
Probable:    Yale University   Contact    
2018
  • Ludwig Institute for Cancer Research, Brussels B-1200, Belgium. · de Duve Institute, University of Louvain, Brussels B-1200, Belgium. · Walloon Excellence in Life Sciences and Biotechnology, Brussels B-1200, Belgium. · Ludwig Institute for Cancer Research, Brussels B-1200, Belgium; · Department of Immunobiology, Yale University, New Haven, CT 06519; and · Department of Cell Biology, Yale University, New Haven, CT 06519. · Pubmed 30135181
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 14 total) written by Benoit J. Van den Eynde about Melanoma:

  • Cytosolic Processing Governs TAP-Independent Presentation of a Critical Melanoma Antigen. 2018
  • Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes. 2017
  • Proteasomes generate spliced epitopes by two different mechanisms and as efficiently as non-spliced epitopes. 2016
  • microRNA-155, induced by interleukin-1ß, represses the expression of microphthalmia-associated transcription factor (MITF-M) in melanoma cells. 2015
  • A spliced antigenic peptide comprising a single spliced amino acid is produced in the proteasome by reverse splicing of a longer peptide fragment followed by trimming. 2014
  • Epithelial-mesenchymal-transition-like and TGFβ pathways associated with autochthonous inflammatory melanoma development in mice. 2012
  • Characterization of T-cell receptors directed against HLA-A*01-restricted and C*07-restricted epitopes of MAGE-A3 and MAGE-A12. 2012
  • Analysis of the processing of seven human tumor antigens by intermediate proteasomes. 2012
  • Disrupted lymph node and splenic stroma in mice with induced inflammatory melanomas is associated with impaired recruitment of T and dendritic cells. 2011
  • An antigenic peptide produced by reverse splicing and double asparagine deamidation. 2011
Show List of Full Article Records
Google Searches

Learn more about Benoit J. Van den Eynde using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Ludwig Institute for Cancer Research - Brussels
Miscellaneous institutions in Brussels
Yale University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Ludwig Institute for Cancer Research - Brussels
2018
  • Ludwig Institute for Cancer Research, Brussels B-1200, Belgium. · de Duve Institute, University of Louvain, Brussels B-1200, Belgium. · Walloon Excellence in Life Sciences and Biotechnology, Brussels B-1200, Belgium. · Ludwig Institute for Cancer Research, Brussels B-1200, Belgium; · Department of Immunobiology, Yale University, New Haven, CT 06519; and · Department of Cell Biology, Yale University, New Haven, CT 06519. · Pubmed 30135181
2017
  • Ludwig Institute for Cancer Research, Brussels, B-1200, Belgium. · de Duve Institute, Université Catholique de Louvain, Brussels, B-1200, Belgium. · Walloon Excellence in Life Sciences and Biotechnology, Brussels, B-1200, Belgium. · Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université, Inserm, CNRS, Marseille, France. · Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, SE-17177, Sweden. · Ludwig Institute for Cancer Research, Brussels, B-1200, Belgium. · de Duve Institute, Université Catholique de Louvain, Brussels, B-1200, Belgium. · Walloon Excellence in Life Sciences and Biotechnology, Brussels, B-1200, Belgium. · Pubmed 29123081
2016
  • Institut für Biochemie, Charité-Universitätsmedizin Berlin, Charitéplatz 1, D-10117 Berlin, Germany. · Ludwig Institute for Cancer Research, WELBIO (Walloon Excellence in Life Sciences and Biotechnology) and the de Duve Institute, Université catholique de Louvain, Place de l'Université 1, B-1200 Brussels, Belgium. · Department of Dermatology, Universitätsklinikum Erlangen, Ulmenweg 18, D-91052 Erlangen, Germany. · Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Essen D - 45122 Essen, Germany &German Cancer Consortium (DKTK), Hufelandstraße 55, D-69120 Heidelberg, Germany. · Max-Delbrück-Center for Molecular Medicine, Robert-Rössle-Str. 10, D-13092 Berlin, Germany. · Institute of Biology, Humboldt University Berlin, Charitéplatz 1, D-10115 Berlin, Germany. · Pubmed 27049119
2015
  • Ludwig Institute for Cancer Research, Brussels and Université Catholique de Louvain, Brussels, Belgium. · de Duve Institute, Université Catholique de Louvain, Brussels, Belgium. · Pubmed 25853464
2014
  • Ludwig Institute for Cancer Research, B-1200 Brussels, Belgium; · Pubmed 24453253
2012
  • Ludwig Institute for Cancer Research, Brussels Branch, B-1200 Brussels, Belgium. · Pubmed 22925930
2011
  • Ludwig Institute for Cancer Research, Brussels Branch, Université Catholique de Louvain, B-1200 Brussels, Belgium. · Pubmed 21670269
  • de Duve Institute, Université Catholique de Louvain and Ludwig Institute for Cancer Research, Brussels Branch, Brussels, Belgium. · Pubmed 21216894
  • Ludwig Institute for Cancer Research, Brussels Branch, Belgium. · Pubmed 21207413
Miscellaneous institutions in Brussels
2018
  • Ludwig Institute for Cancer Research, Brussels B-1200, Belgium. · de Duve Institute, University of Louvain, Brussels B-1200, Belgium. · Walloon Excellence in Life Sciences and Biotechnology, Brussels B-1200, Belgium. · Ludwig Institute for Cancer Research, Brussels B-1200, Belgium; · Department of Immunobiology, Yale University, New Haven, CT 06519; and · Department of Cell Biology, Yale University, New Haven, CT 06519. · Pubmed 30135181
2017
  • Ludwig Institute for Cancer Research, Brussels, B-1200, Belgium. · de Duve Institute, Université Catholique de Louvain, Brussels, B-1200, Belgium. · Walloon Excellence in Life Sciences and Biotechnology, Brussels, B-1200, Belgium. · Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université, Inserm, CNRS, Marseille, France. · Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, SE-17177, Sweden. · Ludwig Institute for Cancer Research, Brussels, B-1200, Belgium. · de Duve Institute, Université Catholique de Louvain, Brussels, B-1200, Belgium. · Walloon Excellence in Life Sciences and Biotechnology, Brussels, B-1200, Belgium. · Pubmed 29123081
Yale University
2018
  • Ludwig Institute for Cancer Research, Brussels B-1200, Belgium. · de Duve Institute, University of Louvain, Brussels B-1200, Belgium. · Walloon Excellence in Life Sciences and Biotechnology, Brussels B-1200, Belgium. · Ludwig Institute for Cancer Research, Brussels B-1200, Belgium; · Department of Immunobiology, Yale University, New Haven, CT 06519; and · Department of Cell Biology, Yale University, New Haven, CT 06519. · Pubmed 30135181
Universite Catholique de Louvain
2017
  • Ludwig Institute for Cancer Research, Brussels, B-1200, Belgium. · de Duve Institute, Université Catholique de Louvain, Brussels, B-1200, Belgium. · Walloon Excellence in Life Sciences and Biotechnology, Brussels, B-1200, Belgium. · Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université, Inserm, CNRS, Marseille, France. · Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, Stockholm, SE-17177, Sweden. · Ludwig Institute for Cancer Research, Brussels, B-1200, Belgium. · de Duve Institute, Université Catholique de Louvain, Brussels, B-1200, Belgium. · Walloon Excellence in Life Sciences and Biotechnology, Brussels, B-1200, Belgium. · Pubmed 29123081
2016
  • Institut für Biochemie, Charité-Universitätsmedizin Berlin, Charitéplatz 1, D-10117 Berlin, Germany. · Ludwig Institute for Cancer Research, WELBIO (Walloon Excellence in Life Sciences and Biotechnology) and the de Duve Institute, Université catholique de Louvain, Place de l'Université 1, B-1200 Brussels, Belgium. · Department of Dermatology, Universitätsklinikum Erlangen, Ulmenweg 18, D-91052 Erlangen, Germany. · Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Essen D - 45122 Essen, Germany &German Cancer Consortium (DKTK), Hufelandstraße 55, D-69120 Heidelberg, Germany. · Max-Delbrück-Center for Molecular Medicine, Robert-Rössle-Str. 10, D-13092 Berlin, Germany. · Institute of Biology, Humboldt University Berlin, Charitéplatz 1, D-10115 Berlin, Germany. · Pubmed 27049119
2015
  • Ludwig Institute for Cancer Research, Brussels and Université Catholique de Louvain, Brussels, Belgium. · de Duve Institute, Université Catholique de Louvain, Brussels, Belgium. · Pubmed 25853464
2011
  • Ludwig Institute for Cancer Research, Brussels Branch, Université Catholique de Louvain, B-1200 Brussels, Belgium. · Pubmed 21670269
  • de Duve Institute, Université Catholique de Louvain and Ludwig Institute for Cancer Research, Brussels Branch, Brussels, Belgium. · Pubmed 21216894
6 Other Locations Show
Yearly article counts 01111103420
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.